WGS insider transactions
GeneDx Holdings Corp. (WGS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for WGS
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $19,092 worth of shares (369 units at $51.74), increasing direct ownership by 1.00% to 35,290 units (SEC Form 4) to cover taxes4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Casdin Capital, Llc bought $21,459,736 worth of shares (500,000 units at $42.92) (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Meister Keith A. bought $13,765,345 worth of shares (351,273 units at $39.19) (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Meister Keith A. bought $46,806,729 worth of shares (1,205,147 units at $38.84) (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- SEC Form 4 filed by Director Casdin Capital, Llc4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $141,595 worth of shares (2,172 units at $65.19), increasing direct ownership by 2% to 93,216 units (SEC Form 4) (for tax liability)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 754 shares and sold $25,555 worth of shares (392 units at $65.19), increasing direct ownership by 1% to 34,942 units (SEC Form 4) to satisfy withholding tax4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- SEC Form 4 filed by Feeley Kevin4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- SEC Form 4 filed by Stueland Katherine4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine sold $1,319,291 worth of shares (17,179 units at $76.80) and converted options into 30,671 shares, increasing direct ownership by 30% to 58,447 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 11,012 shares and sold $438,203 worth of shares (5,706 units at $76.80), increasing direct ownership by 24% to 27,148 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- SEC Form 4 filed by GeneDx Holdings Corp.4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- SEC Form 4 filed by GeneDx Holdings Corp.4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin was granted 1,986 shares, increasing direct ownership by 11% to 20,660 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine was granted 3,404 shares, increasing direct ownership by 9% to 42,087 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Meister Keith A. bought $13,460,090 worth of shares (169,521 units at $79.40) (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Dechairo Bryan4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin was granted 15,262 shares and sold $486,370 worth of shares (6,187 units at $78.61), increasing direct ownership by 95% to 18,674 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine was granted 47,684 shares and sold $2,001,371 worth of shares (25,459 units at $78.61), increasing direct ownership by 135% to 38,683 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 718 shares and sold $22,248 worth of shares (287 units at $77.52), increasing direct ownership by 5% to 9,599 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Chief Operating Officer Dechairo Bryan sold $510,874 worth of shares (5,961 units at $85.70), closing all direct ownership in the company (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Chief Operating Officer Dechairo Bryan converted options into 9,374 shares and sold $339,682 worth of shares (3,413 units at $99.53) (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin sold $29,794 worth of shares (317 units at $93.99) and converted options into 754 shares, increasing direct ownership by 5% to 9,168 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $155,375 worth of shares (1,653 units at $94.00), increasing direct ownership by 16% to 16,458 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $554,616 worth of shares (3,855 units at $143.87), increasing direct ownership by 62% to 8,731 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,562,185 worth of shares (10,857 units at $143.89), increasing direct ownership by 124% to 14,237 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 2,462 shares and sold $201,648 worth of shares (1,266 units at $159.28), increasing direct ownership by 29% to 5,389 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 6,547 shares and sold $579,620 worth of shares (3,639 units at $159.28), increasing direct ownership by 85% to 6,344 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $61,276 worth of shares (377 units at $162.54), increasing direct ownership by 9% to 4,193 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Ruch Joshua sold $6,093,967 worth of shares (38,000 units at $160.37) (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $294,654 worth of shares (2,158 units at $136.54), increasing direct ownership by 100% to 3,436 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 753 shares and sold $52,978 worth of shares (388 units at $136.54), increasing direct ownership by 11% to 3,757 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Amendment: SEC Form 4 filed by Director Meister Keith A.4/A - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine sold $1,390,911 worth of shares (12,858 units at $108.17), decreasing direct ownership by 88% to 1,720 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin exercised 1,246 shares at a strike of $32.67 and sold $716,261 worth of shares (6,609 units at $108.38), decreasing direct ownership by 61% to 3,392 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- SEC Form 4 filed by Director Fuchs Thomas4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- SEC Form 3 filed by new insider Fuchs Thomas3 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Amendment: CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares, increasing direct ownership by 136% to 12,483 units (SEC Form 4)4/A - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin sold $452,850 worth of shares (3,728 units at $121.47), decreasing direct ownership by 56% to 8,755 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,275,585 worth of shares (10,501 units at $121.47), increasing direct ownership by 130% to 14,578 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Chief Executive Officer Stueland Katherine sold $468,297 worth of shares (3,657 units at $128.06) and converted options into 6,546 shares, increasing direct ownership by 84% to 6,329 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin sold $162,886 worth of shares (1,272 units at $128.05) and converted options into 2,462 shares, increasing direct ownership by 29% to 5,286 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $47,556 worth of shares (378 units at $125.81), increasing direct ownership by 9% to 4,096 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Ryan Jason sold $4,995,801 worth of shares (39,222 units at $127.37), decreasing direct ownership by 9% to 11,904 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Casdin Capital, Llc sold $60,451,950 worth of shares (500,000 units at $120.90) (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Amendment: Director Casdin Eli converted options into 12,924 shares, increasing direct ownership by 170% to 20,518 units (SEC Form 4)4/A - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 753 shares and sold $40,860 worth of shares (388 units at $105.31), increasing direct ownership by 11% to 3,757 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Chief Executive Officer Stueland Katherine converted options into 3,874 shares and sold $226,838 worth of shares (2,154 units at $105.31), increasing direct ownership by 100% to 3,440 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin sold $490,854 worth of shares (5,278 units at $93.00) and exercised 1,245 shares at a strike of $32.67, decreasing direct ownership by 54% to 3,392 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Chief Executive Officer Stueland Katherine sold $299,460 worth of shares (3,220 units at $93.00), decreasing direct ownership by 65% to 1,720 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Chief Executive Officer Stueland Katherine sold $878,181 worth of shares (9,657 units at $90.94), decreasing direct ownership by 66% to 4,940 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin sold $122,471 worth of shares (1,344 units at $91.12), decreasing direct ownership by 15% to 7,425 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Casdin Eli converted options into 12,924 shares, increasing direct ownership by 170% to 20,518 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Meister Keith A. converted options into 12,924 shares, increasing direct ownership by 179% to 20,129 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Ryan Jason converted options into 12,924 shares, increasing direct ownership by 9,942% to 13,054 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Leproust Emily M. converted options into 12,924 shares, increasing direct ownership by 155% to 21,276 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Pfenniger Richard C Jr converted options into 12,924 shares, increasing direct ownership by 45% to 41,506 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Director Ruch Joshua converted options into 12,924 shares, increasing direct ownership by 77% to 29,723 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- Chief Executive Officer Stueland Katherine converted options into 18,750 shares and sold $680,181 worth of shares (10,501 units at $64.77), increasing direct ownership by 130% to 14,597 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)
- CHIEF FINANCIAL OFFICER Feeley Kevin sold $241,539 worth of shares (3,729 units at $64.77), decreasing direct ownership by 55% to 8,769 units (SEC Form 4)4 - GeneDx Holdings Corp. (0001818331) (Issuer)